2025 SELECT ABSTRACTS FROM THE 18<sup>th</sup> ANNUAL INTERNATIONAL CONFERENCE ON NEONATAL AND CHILDHOOD PULMONARY VASCULAR DISEASE

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a rare cause of Pulmonary Hypertension (PH) in children.There is limited data on long-term outcomes following pulmonary endarterectomy (PEA) in this demographic.We conducted a retrospective analysis of the United Kingdom National Registry for Paediatric Pulmonary Hypertension (2001-2024) identifying 5 children with CTEPH diagnosed through standardised criteria including cardiac catheterisation and cross-sectional imaging.Among our cohort (60% female, mean age 12 years, range 4-14 years), 80% had identifiable thromboembolic risk factors, predominantly indwelling lines (60%) and thrombophillic conditions (20%).Follow-up duration ranged from 1-5years, with 2 patients followed up for over 4 years.At diagnosis, patients demonstrated reduced exercise capacity (mean six-minute walking distance 361m, range 299-349m) and had echocardiographic evidence of PH (mean TR Vmax 3.67m/s).All patients underwent Cardiac MRI, demonstrating right ventricular (RV) enlargement (mean RV end diastolic volume 109.6ml/m 2 ) and mild-moderate RV systolic impairment (mean RVEF 39.2%).Invasive haemodynamic assessment confirmed significant pressure elevation with mean mPAP 55.6mmHg (range 29-68mmHg) and mean pulmonary vascular resistance index 12.2 WU.m 2 (range 5-21WU.m2).Following PEA (100%), improvements were observed in six-minute walking distance (+45m, p=0.0276),RV volumes (-30ml/m 2 , p=0.0113), RV systolic function (+14.8%,p=0.0031), and haemodynamics (mPAP -28.6mmHg p=0.010;PVRI -11.4WU.m 2 , p=0.0172).However normalisation of pulmonary haemodynamics to mPAP < 20mmHg was achieved in only 1 patient (20%).In this paediatric CTEPH cohort, thromboembolic risk factors were highly prevalent.While PEA resulted in significant haemodynamic and functional improvement, complete normalization of pulmonary haemodynamics was uncommon.This suggests residual PH following PEA may be more frequent in paediatric CTEPH compared to adult cohorts.Longitudinal follow-up into adulthood is important to determine long term outcomes in this population.

Publication Details

Journal
Pulmonary Circulation
Published
2025-07-01
DOI
https://doi.org/10.1002/pul2.70114
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

2025 SELECT ABSTRACTS FROM THE 18th ANNUAL INTERNATIONAL CONFERENCE ON NEONATAL AND CHILDHOOD PULMONARY VASCULAR DISEASE

Pulmonary Circulation
Pulmonary Hypertension Research and Treatments
article

2025 SELECT ABSTRACTS FROM THE 18th ANNUAL INTERNATIONAL CONFERENCE ON NEONATAL AND CHILDHOOD PULMONARY VASCULAR DISEASE

article en

Abstract

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a rare cause of Pulmonary Hypertension (PH) in children.There is limited data on long-term outcomes following pulmonary endarterectomy (PEA) in this demographic.We conducted a retrospective analysis of the United Kingdom National Registry for Paediatric Pulmonary Hypertension (2001-2024) identifying 5 children with CTEPH diagnosed through standardised criteria including cardiac catheterisation and cross-sectional imaging.Among our cohort (60% female, mean age 12 years, range 4-14 years), 80% had identifiable thromboembolic risk factors, predominantly indwelling lines (60%) and thrombophillic conditions (20%).Follow-up duration ranged from 1-5years, with 2 patients followed up for over 4 years.At diagnosis, patients demonstrated reduced exercise capacity (mean six-minute walking distance 361m, range 299-349m) and had echocardiographic evidence of PH (mean TR Vmax 3.67m/s).All patients underwent Cardiac MRI, demonstrating right ventricular (RV) enlargement (mean RV end diastolic volume 109.6ml/m 2 ) and mild-moderate RV systolic impairment (mean RVEF 39.2%).Invasive haemodynamic assessment confirmed significant pressure elevation with mean mPAP 55.6mmHg (range 29-68mmHg) and mean pulmonary vascular resistance index 12.2 WU.m 2 (range 5-21WU.m2).Following PEA (100%), improvements were observed in six-minute walking distance (+45m, p=0.0276),RV volumes (-30ml/m 2 , p=0.0113), RV systolic function (+14.8%,p=0.0031), and haemodynamics (mPAP -28.6mmHg p=0.010;PVRI -11.4WU.m 2 , p=0.0172).However normalisation of pulmonary haemodynamics to mPAP < 20mmHg was achieved in only 1 patient (20%).In this paediatric CTEPH cohort, thromboembolic risk factors were highly prevalent.While PEA resulted in significant haemodynamic and functional improvement, complete normalization of pulmonary haemodynamics was uncommon.This suggests residual PH following PEA may be more frequent in paediatric CTEPH compared to adult cohorts.Longitudinal follow-up into adulthood is important to determine long term outcomes in this population.

Pulmonary CirculationVol. 15(3)
Good health and well-being
Openalex Percentile: Top 74%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

2025 SELECT ABSTRACTS FROM THE 18<sup>th</sup> ANNUAL INTERNATIONAL CONFERENCE ON NEONATAL AND CHILDHOOD PULMONARY VASCULAR DISEASE · Pulmonary Circulation (2025) | TGRS Research Map | TGRS